Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. identifies Nav1.7 channel blockers

June 11, 2018

Prolia approved in Europe for patients with glucocorticoid-induced osteoporosis

June 11, 2018

Bristol-Myers Squibb divulges integrin alphaV antagonists

June 11, 2018

Dana-Farber Cancer Institute patents new PROTAC compounds for cancer

June 11, 2018

Modest data for PI3K inhibitor taselisib in breast cancer

June 11, 2018

Bayer closes its acquisition of Monsanto

June 11, 2018

NOSO-502: a new antibacterial drug candidate active against carbapenem-resistant Enterobacteriaceae

June 11, 2018

FDA approves Rituxan for moderate to severe pemphigus vulgaris

June 11, 2018

FDA approves IND application for clinical study of RK-01

June 11, 2018

Updated interim data from phase I/II study of lumasiran for primary hyperoxaluria type 1

June 8, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...